Cellular Biomedicine Group, Inc. EBITDA Margin 2010-2020 | CBMG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cellular Biomedicine Group, Inc. (CBMG) over the last 10 years. The current EBITDA margin for Cellular Biomedicine Group, Inc. as of September 30, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-09-30 | $0.00B | $-0.05B | inf% |
| 2019-12-31 | $0.00B | $-0.05B | inf% |
| 2019-03-31 | $0.00B | $-0.03B | inf% |
| 2018-12-31 | $0.00B | $-0.03B | inf% |
| 2018-09-30 | $0.00B | $-0.03B | inf% |
| 2018-06-30 | $0.00B | $-0.03B | inf% |
| 2018-03-31 | $0.00B | $-0.03B | inf% |
| 2017-12-31 | $0.00B | $-0.03B | inf% |
| 2017-09-30 | $0.00B | $-0.02B | inf% |
| 2017-06-30 | $0.00B | $-0.03B | inf% |
| 2017-03-31 | $0.00B | $-0.03B | inf% |
| 2016-12-31 | $0.00B | $-0.03B | inf% |
| 2016-09-30 | $0.00B | $-0.03B | -2600.00% |
| 2016-06-30 | $0.00B | $-0.02B | -1050.00% |
| 2016-03-31 | $0.00B | $-0.02B | -666.67% |
| 2015-12-31 | $0.00B | $-0.02B | -475.00% |
| 2015-09-30 | $0.00B | $-0.02B | -633.33% |
| 2015-03-31 | $0.00B | $-0.01B | -1100.00% |
| 2014-12-31 | $0.00B | $-0.01B | inf% |
| 2014-06-30 | $0.00B | $-0.00B | inf% |
| 2013-09-30 | $0.00B | $-0.01B | inf% |
| 2012-12-31 | $0.00B | $-0.01B | inf% |
| 2012-09-30 | $0.00B | $-0.00B | inf% |
| 2012-06-30 | $0.00B | $-0.00B | inf% |
| 2012-03-31 | $0.00B | $-0.00B | inf% |
